• OUTLOOK ARENA
  • VIEWS ON NEWS
  • DECEMBER 2, 2000

Sectoral funds - Weekly round-up

The week saw BSE Sensex appreciating by 1.5% to close at 4,032 points, while the S&P CNX rose 1.7% to close at 1,276 points.

Open-ended, IT FundsNAV
(Rs)
Last
week
Last
month
Last
year
*CAGR
Since inception
Chola Freedom Tech (Cum)13.41.4%3.3%-10.6%10.0%
Sun F&C Emerg Tech (Gr)6.00.3%4.3%0.0%-29.7%
K P Internet Opport.(Gr)6.7-0.4%1.5%0.0%-30.6%
IL&FS eCOM Fund (Gr)5.3-0.9%1.5%0.0%-60.8%
Alliance New Millenn (Gr)7.7-1.3%0.0%0.0%-49.4%
Pru ICICI Tech. (Gr)5.3-1.3%-1.1%0.0%-46.6%
DSP ML Tech.com (Gr)7.0-1.5%0.9%0.0%-17.8%
K Tech6.1-1.6%-0.4%0.0%-21.7%
K P Infotech (Gr)24.8-1.7%0.6%0.9%106.8%
Birla IT Fund (Gr)14.7-1.9%-3.7%-27.4%8.2%
UTI Sector- Software15.0-2.0%1.8%14.3%28.9%
Magnum Sector Funds-IT13.0-2.6%-2.1%-17.5%70.1%
Tata IT Sector Fund9.4-2.7%-3.4%-15.1%15.7%
*CAGR=Compounded Annual Growth Rate

The mood in IT stocks continued to remain subdued as frontline IT stocks Infosys, HCL Tech, Visualsoft, Satyam witnessed selling. Only NIIT and Digital saw some appreciation. Consequently IT funds witnessed declines ranging from 0.4% to nearly 3.0% during the week.

Open-ended, Pharma FundsNAV
(Rs)
Last
week
Last
month
Last
year
*CAGR
Since inception
K P Pharma (Gr)9.61.0%0.8%-29.0%1.4%
UTI Sector-Pharma10.90.9%7.9%-11.6%-5.7%
Magnum Sector Funds-Pharma9.80.2%1.5%-26.5%-2.0%
*CAGR=Compounded Annual Growth Rate

MNC (multinational) pharma stocks (Glaxo, Pfizer, Smithkline Pharma, Novartis) witnessed some appreciation. On the other hand domestic pharma stocks went nowhere. Pharma funds saw marginal appreciation in net asset values (NAVs).

Open-ended, FMCG FundsNAV
(Rs)
Last
week
Last
month
Last
year
*CAGR
Since inception
K P FMCG (Gr) 11.75.3%3.7%-5.0%11.7%
Pru ICICI FMCG (Gr)10.04.5%8.5%-11.7%-2.0%
Magnum Sector Funds-FMCG8.44.0%4.5%-31.8%-10.8%
*CAGR=Compounded Annual Growth Rate

Fast-moving consumer goods (FMCG) stocks (HLL, ITC, Tata Tea) saw some buying interest for a change, reversing the (selling) trend over the past few weeks. FMCG funds reaped the benefits of buying in FMCG counters as is evident from the sharp appreciation in their NAVs.

Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

Equitymaster Agora Research Private Limited (Research Analyst)
103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407